These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26313861)

  • 1. Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms.
    Numano F; Shimizu C; Jimenez-Fernandez S; Vejar M; Oharaseki T; Takahashi K; Salgado A; Tremoulet AH; Gordon JB; Burns JC; Daniels LB
    Int J Cardiol; 2015 Dec; 201():429-37. PubMed ID: 26313861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction.
    Hoshino S; Shimizu C; Jain S; He F; Tremoulet AH; Burns JC
    J Am Heart Assoc; 2020 Jan; 9(1):e014569. PubMed ID: 31880981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Markers of Inflammation Persist in Children and Adults With Giant Aneurysms After Kawasaki Disease.
    Lech M; Guess J; Duffner J; Oyamada J; Shimizu C; Hoshino S; Farutin V; Bulik DA; Gutierrez B; Sarvaiya H; Kapoor B; Koppes L; Saldova R; Stockmann H; Albrecht S; McManus C; Rudd PM; Kaundinya GV; Manning AM; Bosques CJ; Kahn AM; Daniels LB; Gordon JB; Tremoulet AH; Capila I; Gunay NS; Ling LE; Burns JC
    Circ Genom Precis Med; 2019 Apr; 12(4):e002433. PubMed ID: 30844302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium.
    Freeman AF; Crawford SE; Cornwall ML; Garcia FL; Shulman ST; Rowley AH
    Pediatr Cardiol; 2005; 26(5):578-84. PubMed ID: 16132289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.
    Mitani Y; Sawada H; Hayakawa H; Aoki K; Ohashi H; Matsumura M; Kuroe K; Shimpo H; Nakano M; Komada Y
    Circulation; 2005 Jan; 111(1):38-43. PubMed ID: 15611368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a Biomarker.
    Besler C; Lang D; Urban D; Rommel KP; von Roeder M; Fengler K; Blazek S; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
    Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28288987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki Disease: An Autopsy Case Series and Review of the Literature.
    Chang HK; Fernandes J; Nair V
    Am J Forensic Med Pathol; 2016 Sep; 37(3):183-6. PubMed ID: 27281441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopsy-proven myocardial sequels in Kawasaki disease with giant coronary aneurysms.
    Yonesaka S; Takahashi T; Eto S; Sato T; Otani K; Ueda T; Sato A; Kitagawa Y; Konno Y; Kinjo M
    Cardiol Young; 2010 Dec; 20(6):602-9. PubMed ID: 20584347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease.
    Liu AM; Ghazizadeh M; Onouchi Z; Asano G
    Microvasc Res; 1999 Jul; 58(1):10-27. PubMed ID: 10388599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
    López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
    Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular imaging findings with high-pitch low-dose dual-source CT in atypical Kawasaki disease.
    Kantarcı M; Güven E; Ceviz N; Oğul H; Sade R
    Diagn Interv Radiol; 2019 Jan; 25(1):50-54. PubMed ID: 30644368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence.
    Fukazawa R; Ikegam E; Watanabe M; Hajikano M; Kamisago M; Katsube Y; Yamauchi H; Ochi M; Ogawa S
    Circ J; 2007 May; 71(5):709-15. PubMed ID: 17456996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive Coronary Dilatation Predicts Worse Outcome in Kawasaki Disease.
    Chih WL; Wu PY; Sun LC; Lin MT; Wang JK; Wu MH
    J Pediatr; 2016 Apr; 171():78-82.e1. PubMed ID: 26852179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood.
    Shimizu C; Sood A; Lau HD; Oharaseki T; Takahashi K; Krous HF; Campman S; Burns JC
    Cardiovasc Pathol; 2015; 24(5):310-6. PubMed ID: 25791439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
    He J; Li X; Luo H; Li T; Zhao L; Qi Q; Liu Y; Yu Z
    J Am Soc Hypertens; 2017 May; 11(5):275-289.e2. PubMed ID: 28431936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can fibroblast growth factor (FGF)-23 circulating levels suggest coronary artery abnormalities in children with Kawasaki disease?
    Masi L; Franceschelli F; Leoncini G; Gozzini A; Rigante D; La Torre F; Matucci-Cerinic M; Brandi ML; Falcini F
    Clin Exp Rheumatol; 2013; 31(1):149-53. PubMed ID: 23324126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of inflammation and fibrosis in young adults with history of Kawasaki disease.
    Hoshino S; Jain S; Shimizu C; Roberts S; He F; Daniels LB; Kahn AM; Tremoulet AH; Gordon JB; Burns JC
    Int J Cardiol Heart Vasc; 2021 Oct; 36():100863. PubMed ID: 34504945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cardiac function by magnetic resonance imaging during the follow-up of patients with Kawasaki disease.
    Tacke CE; Romeih S; Kuipers IM; Spijkerboer AM; Groenink M; Kuijpers TW
    Circ Cardiovasc Imaging; 2013 Jan; 6(1):67-73. PubMed ID: 23197079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease.
    Xie L; Wang R; Huang M; Zhang Y; Shen J; Xiao T
    Cardiovasc Ultrasound; 2016 Jan; 14():3. PubMed ID: 26754855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease.
    Shimizu C; Oharaseki T; Takahashi K; Kottek A; Franco A; Burns JC
    Hum Pathol; 2013 Feb; 44(2):189-98. PubMed ID: 22955109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.